125 related articles for article (PubMed ID: 2176773)
1. Bone cell responsiveness to transforming growth factor beta, parathyroid hormone, and prostaglandin E2 in normal and postmenopausal osteoporotic women.
Lomri A; Marie PJ
J Bone Miner Res; 1990 Nov; 5(11):1149-55. PubMed ID: 2176773
[TBL] [Abstract][Full Text] [Related]
2. Stimulation of bone formation in osteoporosis patients treated with fluoride associated with increased DNA synthesis by osteoblastic cells in vitro.
Marie PJ; De Vernejoul MC; Lomri A
J Bone Miner Res; 1992 Jan; 7(1):103-13. PubMed ID: 1549953
[TBL] [Abstract][Full Text] [Related]
3. Cellular and molecular effects of growth hormone and estrogen on human bone cells.
Kassem M
APMIS Suppl; 1997; 71():1-30. PubMed ID: 9357492
[TBL] [Abstract][Full Text] [Related]
4. Decreased DNA synthesis by cultured osteoblastic cells in eugonadal osteoporotic men with defective bone formation.
Marie PJ; de Vernejoul MC; Connes D; Hott M
J Clin Invest; 1991 Oct; 88(4):1167-72. PubMed ID: 1918371
[TBL] [Abstract][Full Text] [Related]
5. Development and characterization of a conditionally transformed adult human osteoblastic cell line.
Bodine PV; Trailsmith M; Komm BS
J Bone Miner Res; 1996 Jun; 11(6):806-19. PubMed ID: 8725178
[TBL] [Abstract][Full Text] [Related]
6. Effects of differentiation and transforming growth factor beta 1 on PTH/PTHrP receptor mRNA levels in MC3T3-E1 cells.
McCauley LK; Koh AJ; Beecher CA; Cui Y; Decker JD; Franceschi RT
J Bone Miner Res; 1995 Aug; 10(8):1243-55. PubMed ID: 8585429
[TBL] [Abstract][Full Text] [Related]
7. Mitogenic responsiveness of human bone cells in vitro to hormones and growth factors decreases with age.
Pfeilschifter J; Diel I; Pilz U; Brunotte K; Naumann A; Ziegler R
J Bone Miner Res; 1993 Jun; 8(6):707-17. PubMed ID: 8328313
[TBL] [Abstract][Full Text] [Related]
8. Dexamethasone, BMP-2, and 1,25-dihydroxyvitamin D enhance a more differentiated osteoblast phenotype: validation of an in vitro model for human bone marrow-derived primary osteoblasts.
Jørgensen NR; Henriksen Z; Sørensen OH; Civitelli R
Steroids; 2004 Apr; 69(4):219-26. PubMed ID: 15183687
[TBL] [Abstract][Full Text] [Related]
9. 1,25-dihydroxyvitamin D3-mediated transforming growth factor-beta release is impaired in cultured osteoblasts from patients with multiple pituitary hormone deficiencies.
Sterck JG; Klein-Nulend J; Burger EH; Lips P
J Bone Miner Res; 1996 Mar; 11(3):367-76. PubMed ID: 8852947
[TBL] [Abstract][Full Text] [Related]
10. Influence of the selective oestrogen receptor modulator (raloxifene hydrochloride) on IL-6, TNF-alpha, TGF-beta1 and bone turnover markers in the treatment of postmenopausal osteoporosis.
Ozmen B; Kirmaz C; Aydin K; Kafesciler SO; Guclu F; Hekimsoy Z
Eur Cytokine Netw; 2007 Sep; 18(3):148-53. PubMed ID: 17823083
[TBL] [Abstract][Full Text] [Related]
11. Parathyroid hormone stimulation and PKA signaling of latent transforming growth factor-beta binding protein-1 (LTBP-1) mRNA expression in osteoblastic cells.
Kwok S; Qin L; Partridge NC; Selvamurugan N
J Cell Biochem; 2005 Aug; 95(5):1002-11. PubMed ID: 15880704
[TBL] [Abstract][Full Text] [Related]
12. Prostaglandin E2 stimulates the formation of mineralized bone nodules by a cAMP-independent mechanism in the culture of adult rat calvarial osteoblasts.
Kaneki H; Takasugi I; Fujieda M; Kiriu M; Mizuochi S; Ide H
J Cell Biochem; 1999 Apr; 73(1):36-48. PubMed ID: 10088722
[TBL] [Abstract][Full Text] [Related]
13. Osteocalcin and deoxyribonucleic acid synthesis in vitro and histomorphometric indices of bone formation in postmenopausal osteoporosis.
Marie PJ; Sabbagh A; de Vernejoul MC; Lomri A
J Clin Endocrinol Metab; 1989 Aug; 69(2):272-9. PubMed ID: 2787799
[TBL] [Abstract][Full Text] [Related]
14. Normal osteoclastic and osteoblastic responses to exogenous growth hormone in patients with postmenopausal spinal osteoporosis.
Kassem M; Brixen K; Blum WF; Mosekilde L; Eriksen EF
J Bone Miner Res; 1994 Sep; 9(9):1365-70. PubMed ID: 7817819
[TBL] [Abstract][Full Text] [Related]
15. Parathyroid hormone enhances bone morphogenetic protein activity by increasing intracellular 3', 5'-cyclic adenosine monophosphate accumulation in osteoblastic MC3T3-E1 cells.
Nakao Y; Koike T; Ohta Y; Manaka T; Imai Y; Takaoka K
Bone; 2009 May; 44(5):872-7. PubMed ID: 19442611
[TBL] [Abstract][Full Text] [Related]
16. Ultrahigh molecular weight polyethylene particles have direct effects on proliferation, differentiation, and local factor production of MG63 osteoblast-like cells.
Dean DD; Schwartz Z; Blanchard CR; Liu Y; Agrawal CM; Lohmann CH; Sylvia VL; Boyan BD
J Orthop Res; 1999 Jan; 17(1):9-17. PubMed ID: 10073642
[TBL] [Abstract][Full Text] [Related]
17. Osteoblast-like cells from human subchondral osteoarthritic bone demonstrate an altered phenotype in vitro: possible role in subchondral bone sclerosis.
Hilal G; Martel-Pelletier J; Pelletier JP; Ranger P; Lajeunesse D
Arthritis Rheum; 1998 May; 41(5):891-9. PubMed ID: 9588742
[TBL] [Abstract][Full Text] [Related]
18. Differential effects of retinoic acid and growth factors on osteoblastic markers and CD10/NEP activity in stromal-derived osteoblasts.
Benayahu D; Fried A; Shamay A; Cunningham N; Blumberg S; Wientroub S
J Cell Biochem; 1994 Sep; 56(1):62-73. PubMed ID: 7528753
[TBL] [Abstract][Full Text] [Related]
19. Bone morphogenetic proteins (BMP-2 and BMP-3) promote growth and expression of the differentiated phenotype of rabbit chondrocytes and osteoblastic MC3T3-E1 cells in vitro.
Hiraki Y; Inoue H; Shigeno C; Sanma Y; Bentz H; Rosen DM; Asada A; Suzuki F
J Bone Miner Res; 1991 Dec; 6(12):1373-85. PubMed ID: 1665281
[TBL] [Abstract][Full Text] [Related]
20. Normal parathyroid hormone responsiveness of bone-derived cells from a patient with pseudohypoparathyroidism.
Ish-Shalom S; Rao LG; Levine MA; Fraser D; Kooh SW; Josse RG; McBroom R; Wong MM; Murray TM
J Bone Miner Res; 1996 Jan; 11(1):8-14. PubMed ID: 8770691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
